Deficiency in IL-33/ST2 Axis Reshapes Mitochondrial Metabolism in Lipopolysaccharide-Stimulated Macrophages (Q61803785)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30774633 AND SRC:MED&resulttype=core&format=json

23 April 2020

title

Deficiency in IL-33/ST2 Axis Reshapes Mitochondrial Metabolism in Lipopolysaccharide-Stimulated Macrophages (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30774633 AND SRC:MED&resulttype=core&format=json

23 April 2020

0 references

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30774633 AND SRC:MED&resulttype=core&format=json

23 April 2020

author name string

Huadan Xu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30774633 AND SRC:MED&resulttype=core&format=json

23 April 2020

Liankun Sun

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30774633 AND SRC:MED&resulttype=core&format=json

23 April 2020

Yichun He

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30774633 AND SRC:MED&resulttype=core&format=json

23 April 2020

Xiaofeng Yuan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30774633 AND SRC:MED&resulttype=core&format=json

23 April 2020

Junqi Niu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30774633 AND SRC:MED&resulttype=core&format=json

23 April 2020

Jing Su

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30774633 AND SRC:MED&resulttype=core&format=json

23 April 2020

language of work or name

English

0 references

publication date

1 February 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30774633 AND SRC:MED&resulttype=core&format=json

23 April 2020

published in

Frontiers in Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30774633 AND SRC:MED&resulttype=core&format=json

23 April 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30774633 AND SRC:MED&resulttype=core&format=json

23 April 2020

page(s)

127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30774633 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

23 April 2020

copyright license

start time

1 February 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression

1 reference

12 December 2020

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

1 reference

12 December 2020

Arginine metabolism: boundaries of our knowledge

1 reference

12 December 2020

Interleukin-33 - cytokine of dual function or novel alarmin?

1 reference

12 December 2020

IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex

1 reference

12 December 2020

IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation

1 reference

12 December 2020

Role of interleukin 33 in human immunopathology.

1 reference

12 December 2020

IL-33 exacerbates autoantibody-induced arthritis

1 reference

12 December 2020

Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection

1 reference

12 December 2020

Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice

1 reference

12 December 2020

Elevated Serum Interleukin 33 Is Associated with Autoantibody Production in Patients with Rheumatoid Arthritis

1 reference

12 December 2020

IL-33 Exacerbates Eosinophil-Mediated Airway Inflammation

1 reference

12 December 2020

Interleukin-33 contributes to both M1 and M2 chemokine marker expression in human macrophages

1 reference

12 December 2020

IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages.

1 reference

12 December 2020

Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists

1 reference

12 December 2020

Interleukin-33 exacerbates acute colitis via interleukin-4 in mice

1 reference

12 December 2020

Hypoxia-inducible factor-1α and interleukin 33 form a regulatory circuit to perpetuate the inflammation in rheumatoid arthritis

1 reference

12 December 2020

Increased IL-33 in synovial fluid and paired serum is associated with disease activity and autoantibodies in rheumatoid arthritis

1 reference

12 December 2020

Emerging role of interleukin-33 in autoimmune diseases

1 reference

12 December 2020

IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice.

1 reference

12 December 2020

Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation.

1 reference

12 December 2020

IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice

1 reference

12 December 2020

IL-33 attenuates the development of experimental autoimmune uveitis.

1 reference

12 December 2020

Metabolic reprograming in macrophage polarization.

1 reference

12 December 2020

Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the warburg effect in LPS-activated macrophages

1 reference

12 December 2020

Dual function of IL-33 on proliferation of NIH-3T3 cells.

1 reference

12 December 2020

IL-33-mediated protection against experimental cerebral malaria is linked to induction of type 2 innate lymphoid cells, M2 macrophages and regulatory T cells

1 reference

12 December 2020

Time and Demand are Two Critical Dimensions of Immunometabolism: The Process of Macrophage Activation and the Pentose Phosphate Pathway

1 reference

12 December 2020

Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways.

1 reference

12 December 2020

Macrophages in Tissue Repair, Regeneration, and Fibrosis

1 reference

12 December 2020

SIRT3 participates in glucose metabolism interruption and apoptosis induced by BH3 mimetic S1 in ovarian cancer cells.

1 reference

12 December 2020

A Novel Application of Ti-Substituted Polyoxometalates: Anti-Inflammatory Activity in OVA-Induced Asthma Murine Model.

1 reference

12 December 2020

Interleukin-33 in health and disease

1 reference

12 December 2020

Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS.

1 reference

12 December 2020

Endogenous prostaglandin E2 amplifies IL-33 production by macrophages through an E prostanoid (EP)2/EP4-cAMP-EPAC-dependent pathway.

1 reference

12 December 2020

IL-33 contributes to sepsis-induced long-term immunosuppression by expanding the regulatory T cell population.

1 reference

12 December 2020

Macrophage Immunometabolism: Where Are We (Going)?

1 reference

12 December 2020

Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.

1 reference

12 December 2020

Mitochondrial control of immunity: beyond ATP.

1 reference

12 December 2020

Targeting IL-33/ST2 signaling: regulation of immune function and analgesia

1 reference

12 December 2020

PGC1α promotes cisplatin resistance in human ovarian carcinoma cells through upregulation of mitochondrial biogenesis

1 reference

12 December 2020

Identifiers

DOI

10.3389/FIMMU.2019.00127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30774633 AND SRC:MED&resulttype=core&format=json

23 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30774633 AND SRC:MED&resulttype=core&format=json

23 April 2020

PubMed publication ID

30774633

1 reference